Theralink Technologies, Inc. (THER)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 31, 2025
Theralink Technologies Employees
Theralink Technologies had 16 employees as of September 30, 2023. The number of employees decreased by 3 or -15.79% compared to the previous year.
Employees
16
Change (1Y)
-3
Growth (1Y)
-15.79%
Revenue / Employee
$39,716
Profits / Employee
-$843,612
Market Cap
6.15K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2023 | 16 | -3 | -15.79% | 16 | 0 |
| Sep 30, 2022 | 19 | 3 | 18.75% | 19 | 0 |
| Sep 30, 2021 | 16 | 4 | 33.33% | 16 | 0 |
| Sep 30, 2020 | 12 | 10 | 500.00% | 12 | 0 |
| Dec 31, 2019 | 2 | -1 | -33.33% | 2 | 0 |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Theralink Technologies News
- 2 years ago - Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates - GlobeNewsWire
- 2 years ago - Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4 - GlobeNewsWire
- 2 years ago - Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board - GlobeNewsWire
- 2 years ago - Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023 - GlobeNewsWire
- 2 years ago - Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer - GlobeNewsWire
- 2 years ago - THERALINK INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Theralink Technologies, Inc. - THER - Business Wire
- 3 years ago - Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University - PRNewsWire
- 3 years ago - Theralink® Technologies Begins Receiving Payments from Third Party Payors for its Advanced Breast Cancer Assay, Achieving Key Milestone - PRNewsWire